Nephrogenic Systemic Fibrosis
📧 Sign up to get email alerts when something new happens for Nephrogenic Systemic Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration
An observational study assessing the incidence of nephrogenic systemic fibrosis in patients with renal impairment after administration of Do…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Pilot Study of Imatinib Mesylate to Treat Nephrogenic Systemic Fibrosis [Phase 2]
Phase 2 pilot trial evaluating imatinib mesylate for treating nephrogenic systemic fibrosis; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Nephrogenic Systemic Fibrosis (NSF): Analysis of Tissue Gadolinium Levels
Completed clinical trial analyzing tissue gadolinium levels in patients with nephrogenic systemic fibrosis to explore exposure and potential…
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF) [Phase 4]
Phase 4 trial investigating plasmapheresis for nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR
This completed prospective trial evaluated the incidence of nephrogenic systemic fibrosis in patients with kidney disease undergoing magneti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-09-18Clinical Trial Update: Evaluation of the Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents (GBCA)
This completed clinical trial evaluated the risk of nephrogenic systemic fibrosis in patients with chronic kidney disease who had no exposur…
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: Nephrogenic Systemic Fibrosis With Gadollinum [Phase 2, Phase 3]
Phase 2/Phase 3 trial investigating Gadollinum for Nephrogenic Systemic Fibrosis in patients with renal failure. The status of the trial is …
-
CLINICAL_TRIALS trial_result · 2012-06-05Clinical Trial Update: Treatment of Patients With Nephrogenic Systemic Fibrosis With Glivec [Phase 3]
Phase 3 trial evaluating imatinib (Glivec) for nephrogenic systemic fibrosis has completed.